We narrowed to 40,521 results for: ANT
-
Plasmid#64638Purpose3rd generation lentiviral transfer plasmid. When used to produce lentivirus, express physiological levels of insertDepositorAvailable SinceDec. 1, 2015AvailabilityAcademic Institutions and Nonprofits only
-
Anti-Pan-Gamma-protocadherin-Constant [N159/5R]
Plasmid#177503PurposeMammalian Expression Plasmid of anti-Pan-Gamma-protocadherin-Constant (Mouse). Derived from hybridoma N159/5.DepositorInsertanti-Pan-Gamma-protocadherin-Constant (Mus musculus) recombinant mouse monoclonal antibody
ExpressionMammalianPromoterDual CMVAvailable SinceJan. 6, 2022AvailabilityAcademic Institutions and Nonprofits only -
Sars Cov 2 MPRO R188S mutantSARS-CoV-2 Mpro protease (R188S mutant - clinical mutant); aliases: 3CLpro, 3C-like
Plasmid#204785PurposeBacterial expression of Sars Cov 2 MPRO R188S mutantDepositorAvailable SinceJan. 23, 2024AvailabilityIndustry, Academic Institutions, and Nonprofits -
pAAV-UAS-anti-CD3/anti-CD19 BiTE
Plasmid#230005PurposeGal4-dependent expression of secreted BiTEDepositorInsertUAS-anti-CD3/anti-CD19 BiTE
UseAAVExpressionMammalianPromoterUASAvailable SinceJan. 6, 2025AvailabilityAcademic Institutions and Nonprofits only -
pLN539 (FuGW-G8p-antiPD1(HC)-P2A-antiPD1(LC)-1Pe)
Plasmid#105200PurposeModule 3 - GAL4 synthetic promoter (with eight binding sites) drives the expression of anti-PD1 Ab transcripts containing miR1-Bs(Pe)DepositorInsertG8p-antiPD1(HC)-P2A-antiPD1(LC)
UseLentiviral and Synthetic BiologyExpressionMammalianAvailable SinceApril 4, 2018AvailabilityAcademic Institutions and Nonprofits only -
Anti-TRIP8b (constant) ion channel [N212/27R]
Plasmid#220409PurposeMammalian Expression Plasmid of anti-TRIP8b (constant) ion channel (Rat) IgG2a R-mAb. Derived from hybridoma N212/27.DepositorInsertAnti-TRIP8b (constant) ion channel (Rattus novegicus) recombinant mouse monoclonal antibody. (Pex5l Mouse)
ExpressionMammalianPromoterDual CMVAvailable SinceSept. 5, 2024AvailabilityAcademic Institutions and Nonprofits only -
LV anti-FITC-LaG16-Y186F/Y229A-2Xmutant-T2A-BFP
Plasmid#194934PurposeLV construct encoding Y186F/Y229A double mutant sNRR-based SynNotch receptorDepositorInsertantiFITC-LaG16-sNRR(Y186F/Y229A)-SynNotch-Gal4-VP64-T2A-BFP
UseLentiviral and Synthetic BiologyAvailable SinceApril 21, 2023AvailabilityAcademic Institutions and Nonprofits only -
Anti-Pan-Gamma-protocadherin-Constant [N159/5-rat IgG2a] - Chimeric
Plasmid#227069PurposeMammalian expression plasmid of anti-Pan-Gamma-protocadherin-Constant (Mus musculus) rat IgG2a R-mAb. Derived from hybridoma N159/5.DepositorInsertAnti-Pan-Gamma-protocadherin-Constant recombinant mouse monoclonal antibody.
UseAffinity Reagent/ AntibodyExpressionMammalianPromoterDual CMVAvailable SinceJan. 21, 2025AvailabilityAcademic Institutions and Nonprofits only -
SARS-CoV-2 Mpro protease (M165I mutant - clinical mutant); aliases: 3CLpro, 3C-like
Plasmid#204778PurposeBacterial expression of Sars Cov 2 MPRO M165I mutantDepositorAvailable SinceDec. 1, 2023AvailabilityIndustry, Academic Institutions, and Nonprofits -
SARS-CoV-2 Mpro protease (T190I mutant - clinical mutant); aliases: 3CLpro, 3C-like
Plasmid#204786PurposeBacterial expression of Sars Cov 2 MPRO T190I mutantDepositorAvailable SinceJan. 23, 2024AvailabilityIndustry, Academic Institutions, and Nonprofits -
SARS-CoV-2 Mpro protease (Q189K mutant - clinical mutant); aliases: 3CLpro, 3C-like
Plasmid#204784PurposeBacterial expression of Sars Cov 2 MPRO Q189K mutantDepositorAvailable SinceJan. 23, 2024AvailabilityIndustry, Academic Institutions, and Nonprofits -
SARS-CoV-2 Mpro protease (P132H mutant - clinical mutant); aliases: 3CLpro, 3C-like
Plasmid#204783PurposeBacterial expression of Sars Cov 2 MPRO P132H mutantDepositorAvailable SinceJan. 23, 2024AvailabilityIndustry, Academic Institutions, and Nonprofits -
SARS-CoV-2 Mpro protease (N142S mutant - clinical mutant); aliases: 3CLpro, 3C-like
Plasmid#204782PurposeBacterial expression of Sars Cov 2 MPRO N142S mutantDepositorAvailable SinceJan. 23, 2024AvailabilityIndustry, Academic Institutions, and Nonprofits -
SARS-CoV-2 Mpro protease (M49T mutant - clinical mutant); aliases: 3CLpro, 3C-like
Plasmid#204779PurposeBacterial expression of Sars Cov 2 MPRO M49T mutantDepositorAvailable SinceJan. 23, 2024AvailabilityIndustry, Academic Institutions, and Nonprofits -
SARS-CoV-2 Mpro protease (M491I mutant - clinical mutant); aliases: 3CLpro, 3C-like
Plasmid#204777PurposeBacterial expression of Sars Cov 2 MPRO M49I mutantDepositorAvailable SinceJan. 23, 2024AvailabilityIndustry, Academic Institutions, and Nonprofits -
SARS-CoV-2 Mpro protease (G143S mutant - clinical mutant); aliases: 3CLpro, 3C-like
Plasmid#204776PurposeBacterial expression of Sars Cov 2 MPRO G143S mutantDepositorAvailable SinceJan. 23, 2024AvailabilityIndustry, Academic Institutions, and Nonprofits -
SARS-CoV-2 Mpro protease (A191V mutant - clinical mutant); aliases: 3CLpro, 3C-like
Plasmid#204774PurposeBacterial expression of Sars Cov 2 MPRO A191V mutantDepositorAvailable SinceJan. 23, 2024AvailabilityIndustry, Academic Institutions, and Nonprofits -
SARS-CoV-2 Mpro protease (A193T mutant - clinical mutant); aliases: 3CLpro, 3C-like
Plasmid#204773PurposeBacterial expression of Sars Cov 2 MPRO A193T mutantDepositorAvailable SinceJan. 23, 2024AvailabilityIndustry, Academic Institutions, and Nonprofits -
SARS-CoV-2 Mpro protease (A191T mutant - clinical mutant); aliases: 3CLpro, 3C-like
Plasmid#204772PurposeBacterial expression of Sars Cov 2 MPRO A191T mutantDepositorAvailable SinceJan. 23, 2024AvailabilityIndustry, Academic Institutions, and Nonprofits -
SARS-CoV-2 Mpro protease (A193S mutant - clinical mutant); aliases: 3CLpro, 3C-like
Plasmid#204771PurposeBacterial expression of Sars Cov 2 MPRO A193S mutantDepositorAvailable SinceJan. 23, 2024AvailabilityIndustry, Academic Institutions, and Nonprofits